Antiviral Therapies against Corona Virus – In the new era of COVID-19 pandemic

ABSTRACT

Today the entire world is suffering from coronavirus (COVID-19) disease, with regards to the treatment of this many therapies used, amongst them antiviral therapy is on the top of the list. Many healthcare professionals and pharmaceutical companies focusing their path on the effectiveness of antiviral treatment conducted so many clinical trials of antiviral therapy. The effectiveness of antiviral drugs against coronavirus is still controversial. In the treatment of coronavirus, various antiviral drugs like remdesivir, HCQ, CQ, LPV/r, IFN, camostat mesylate, favipiravir, nitazoxanide, ribavirin, etc used and results of those drugs are analyzed based on their clinical reports. In present review mention various findings and the latest progress in antiviral therapy, to support ongoing numbers of clinical studies for better management against virus. Also, include detailed analysis of antiviral therapy results of various clinical studies with core discussion on the efficacy of antiviral treatments. In the treatment of coronavirus, it is necessary to summarize various clinical studies cover antiviral therapy to ensure the efficacy and safety of drugs or treatment for the betterment of making healthy mankind.